P1740: HEALTH‐RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IDECABTAGENE VICLEUCEL VS BELANTAMAB MAFODOTIN: A MATCHING‐ADJUSTED INDIRECT COMPARISON STUDY.

Autor: Shah, N., Ayers, D., Cope, S., Karampampa, K., Towle, K., Braverman, J., Mojebi, A., Caisip, C., Dhanda, D.
Zdroj: HemaSphere; 2022 Supplement 3, Vol. 6, p1621-1622, 2p
Databáze: Complementary Index
Externí odkaz: